There will be no buy out. So no worries... Nader believes
There will be no buy out. So no worries... Nader believes we are currently worth 5-6 times our current stock price. He wouldn’t entertain a low ball offer. That’s a beautiful thing. I would dread a buy out. I hope we do our trials ourself and become a first rate pharmaceutical company with the caring people that already bust their butts to help save lives with EIND’s until we unleash Vyrologix to all that need it.
We will soon all get aboard the approval train and start knocking out approvals by the handful each year. If you remember the Cytodyn Board of Director’s goals were set at 10 indications a year for new trials. With choosing saving lives as the indications that get trialed first. Those just happen to be the highest return indications also. Saving lives is big money.
Then we will all be happy that we stayed in CYDY for the long term. I still want to believe what our CEO Nader said “ this stock could be a high triple digit stock or even a quadruple digit stock some day. I am hoping some day is only 3-5 years with the blockbuster indications we will be chasing. If we are approved on the top 10 indications Leronlimab has been speculated to work for. Then it’s easy to see a $1,000/share stock price. That’s the dream people. Let’s not lose sight of what could happen. Let’s just hope that all the signs that have pointed us here will fill our dreams with everything we hope to be true. Today we get a current map of our predicted progress for 2021 in the conference call. It’s going to be a blockbuster year in my opinion. Every day we are getting closer. Our day is coming soon. Approve Leronlimab now... save lives now...
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nippon Steel’s Drive to Acquire U.S. Steel Reaches a Critical Stage Nippon Steel Corp.’s vice chairman, Takahiro Mori, is heading to the United States to press forward on the company’s proposed $15 billion purchase of United States Steel Corp. His trip centers on meetings with key U.S. officials to work through concerns about foreign ownership and what it might mean...
Continue Reading
Universal Electronics Partners with Somfy for New Smart Solutions Universal Electronics Inc. (NASDAQ: UEIC), a leader in wireless control technology, has teamed up with Somfy, a pioneer in window and door automation. Their collaboration aims to develop a variety of innovative wireless remote control and sensor products specifically designed for smart motorized shade...
Continue Reading
Overview of Unicycive Therapeutics Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is driving advancements in biotechnology, focusing on developing treatments that address critical medical needs. The company is particularly dedicated to addressing conditions related to kidney disease, an area where they aspire to make a significant impact. Details of the Class Action Lawsuit...
Continue Reading
Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...
Continue Reading
Overview of Bayport Management Ltd's Financial Report Bayport Management Ltd has recently published its audited abridged financial report for December 2023. This report offers valuable insights into the company's performance and overall financial health, providing a clear overview of its operations during this period. Financial Highlights The financial report for December...
Continue Reading